/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

H

Hirotsugu Kenmotsu

Shizuoka Cancer Center(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

496

Papers

8.0K

Citations

41

h-index

153

i10-index

Hirotsugu Kenmotsu is an academic researcher from Shizuoka Cancer Center. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Lung Cancer Diagnosis and Treatment. The author has an h-index of 41, co-authored 422 publications.

ORCID: 0000-0003-0590-9259

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Lung Cancer Diagnosis and Treatment Cancer Genomics and Diagnostics Gastrointestinal Tumor Research and Treatment

Papers by this author

works

Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study

2017 · BMC Cancer · 63 citations

https://doi.org/10.1186/s12885-017-3795-2

Tateaki Naito Taro Okayama Takashi Aoyama Takuya Ohashi

Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors

2016 · Investigational New Drugs · 61 citations

https://doi.org/10.1007/s10637-016-0371-6

Hidenori Mizugaki Noboru Yamamoto Haruyasu Murakami Hirotsugu Kenmotsu

Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients

2016 · BMC Cancer · 51 citations

https://doi.org/10.1186/s12885-016-2902-0

Ryo Ko Hirotsugu Kenmotsu Masakuni Serizawa Yasuhiro Koh

Osimertinib-induced interstitial lung disease after treatment with anti-PD1 antibody

2016 · Investigational New Drugs · 50 citations

https://doi.org/10.1007/s10637-016-0389-9

Nobuaki Mamesaya Hirotsugu Kenmotsu Mineo Katsumata Takashi Nakajima

Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non–Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis

2017 · Clinical Lung Cancer · 46 citations

https://doi.org/10.1016/j.cllc.2017.06.003

Kohei Otsubo Junji Kishimoto Hirotsugu Kenmotsu Yuji Minegishi

Comparison of clinical features between immune-related sclerosing cholangitis and hepatitis

2021 · Investigational New Drugs · 35 citations

https://doi.org/10.1007/s10637-021-01136-z

Masaki Takinami Akira Ono Takanori Kawabata Nobuaki Mamesaya

Research topics

topics

Lung Cancer Treatments and Mutations

Lung Cancer Research Studies

Lung Cancer Diagnosis and Treatment

Cancer Genomics and Diagnostics

Gastrointestinal Tumor Research and Treatment

Chat about Author

Papers

Chat

Click to start Chat